Adial Pharmaceuticals, Inc. (ADIL)
NASDAQ: ADIL · Real-Time Price · USD
3.340
+0.050 (1.52%)
At close: Jul 31, 2026, 4:00 PM EDT
3.200
-0.140 (-4.19%)
After-hours: Jul 31, 2026, 7:34 PM EDT

Adial Pharmaceuticals Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Income
-7.53-7.8-8.28-6.89-10.86-19.29
Net Income
-7.77-7.98-13.2-5.12-12.73-19.42
Earnings Per Share
-8.66-11.93-68.01-90.00-317.75-650.00
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
4.585.883.752.8346.06
Total Debt
000000.26
Net Cash (Debt)
4.585.883.752.8345.81
Net Cash Growth
93.77%56.81%32.66%-29.35%-31.07%31.90%
Net Cash Per Share
4.868.8019.3349.6199.89195.19

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-6.52-6.49-6.92-6.81-11.19-11.95
Capital Expenditures
------0.06
Free Cash Flow
-6.52-6.49-6.92-6.81-11.19-12.01
Free Cash Flow Growth
------

Valuation

Selected indicators aren't available for this stock.